Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Investigate LYL797 in Adults With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Phase I/II Study of SY-3505 in Patients With ALK-positive Advanced Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLC
- Status
- RECRUITING
- Phase
- PHASE1
An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Pulmonary Magnetic Resonance-guided Online Adaptive Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA